Solentim features on podcast “New Matter: Inside the Minds of SLAS Scientists”

Following Solentim’s new ICON instrument winning the SLAS 2021 New Product Award, Duncan Borthwick, Global Marketing Manager, was invited to discuss Solentim’s innovative products, mission and vision on the New Matter Podcast. Duncan discusses how the company is dedicated to listening to scientists to make better tools to improve cell line development, and shares how …

Read more Solentim features on podcast “New Matter: Inside the Minds of SLAS Scientists”

Solentim China Team

Solentim expands global reach, opening new operation in China

Bournemouth, UK, 23rd February 2021 / Solentim, the trusted global leader in cell therapy workflows enabling the creation, isolation and characterization of high value cells, announces the opening of a new office in Shanghai. Solentim China is a joint venture with its longstanding distribution partner Trio Biotech Co, and will enhance support for customers and expand …

Read more Solentim expands global reach, opening new operation in China

SLAS new product award banner image

Solentim wins New Product Award at SLAS 2021

Bournemouth, UK, 29th January 2021 / Solentim is delighted to have won a New Product Award from the Society for Laboratory Automation and Screening (SLAS), announced this week at SLAS Digital 2021. Solentim achieved this award with the launch of its new ICON™ and STUDIUS™ technologies. ICON is the world’s first benchtop system for characterizing high …

Read more Solentim wins New Product Award at SLAS 2021

Redefining cell line development

Following the launch of Solentim’s new ICON™ instrument and dedicated STUDIUS™ software, the two of which complete the company’s cutting-edge ecosystem, we spoke with Dr Ian Taylor, Chief Business Officer, Solentim, to find out what this means for cell line development and the future of antibody therapeutics.

Read more Redefining cell line development

ICON

Solentim sets new standards in productivity with the launch of ICON™ and STUDIUS™; accelerating assurance rich workflows in the development of new biologics

Bournemouth, UK, 25th January 2021 / Solentim, the trusted global leader in cell therapy workflows enabling the creation, isolation and characterization of high value cells, is delighted to launch two new solutions to enhance the development of therapeutic antibodies. ICON™ is a benchtop system for the rapid stratification of high productivity clones and STUDIUS™ is a proprietary …

Read more Solentim sets new standards in productivity with the launch of ICON™ and STUDIUS™; accelerating assurance rich workflows in the development of new biologics

Why Evercell Bio chose VIPS: a new workflow for hiPSC in cell therapy

Philip D. Manos, Founder and President of EverCell Bio, Natick, Massachusetts, USA “Our mission is to accelerate the implementation of human and disease-specific stem cell technologies for drug discovery and personalized medicine” EverCell Bio is a single-source provider of customized services for the application of stem cell technology in cell therapy. EverCell offers human cell-modelling …

Read more Why Evercell Bio chose VIPS: a new workflow for hiPSC in cell therapy